PRESS RELEASE published on 07/02/2025 at 07:00, 9 months ago BIOVERSYS AND SHIONOGI ENTER INTO GLOBAL RESEARCH COLLABORATION FOR BROAD-SPECTRUM NON-TUBERCULOUS MYCOBACTERIA (NTM) CLINICAL CANDIDATE BioVersys and Shionogi enter global research collaboration for NTM clinical candidate. BioVersys grants Shionogi license option for leads from BV500 program Shionogi BioVersys Global Research Collaboration NTM Clinical Candidate
BRIEF published on 06/30/2025 at 07:05, 9 months 2 days ago BioVersys AG Annual General Meeting Yields Positive Outcomes Financial Statements Strategic Initiatives Board Elections BioVersys AGM Capital Amendment
BRIEF published on 06/30/2025 at 07:05, 9 months 2 days ago L'assemblée générale annuelle de BioVersys AG donne des résultats positifs États Financiers Élections Du Conseil D'administration Initiatives Stratégiques Assemblée Générale Annuelle De BioVersys Amendement Capital
PRESS RELEASE published on 06/30/2025 at 07:00, 9 months 2 days ago BIOVERSYS ANNOUNCES RESULTS FROM its ANNUAL GENERAL MEETING OF SHAREHOLDERS BioVersys AG announces results from its Annual General Meeting of Shareholders, including re-election of Board Members and amendment to capital range for strategic initiatives Annual General Meeting Shareholders Board Members BioVersys AG Capital Range
BRIEF published on 06/03/2025 at 07:05, 9 months 29 days ago BioVersys annonce l'assemblée générale annuelle des actionnaires de 2025 Augmentation De Capital Élections Du Conseil D'administration Assemblée Générale Des Actionnaires Assemblée Générale Annuelle 2025 BioVersys AG
BRIEF published on 06/03/2025 at 07:05, 9 months 29 days ago BioVersys Announces 2025 Annual General Meeting of Shareholders Capital Increase Board Elections Shareholders Meeting 2025 AGM BioVersys AG
PRESS RELEASE published on 06/03/2025 at 07:00, 9 months 29 days ago BioVersys publishes Invitation to its ANNUAL GENERAL MEETING OF SHAREHOLDERS 2025 BioVersys AG publishes Invitation to its Annual General Meeting of Shareholders 2025, including agenda with items such as annual report, elections, compensation approval, and capital range amendment Annual General Meeting Shareholders Biopharmaceutical AGM 2025 BioVersys AG
BRIEF published on 04/28/2025 at 07:05, 11 months 4 days ago BioVersys organise un événement virtuel sur l'étude BV100 pour VABP Événement Virtuel BioVersys AG Étude BV100 Traitement VABP Résistance Aux Carbapénèmes
BRIEF published on 04/28/2025 at 07:05, 11 months 4 days ago BioVersys to Host Virtual Event on BV100 Study for VABP Virtual Event BioVersys AG BV100 Study VABP Treatment Carbapenem Resistance
PRESS RELEASE published on 04/28/2025 at 07:00, 11 months 4 days ago BioVersys to Host Virtual KOL Event to Discuss BV100 Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter on May 7, 2025 BioVersys AG to host virtual KOL event featuring Prof. David Paterson & Dr. Andrew Shorr on BV100 Phase 2 VABP study against CRAB. Register for insights on May 7, 2025 Virtual Event BioVersys AG Antibacterial Products Multidrug-resistant Bacteria Key Opinion Leaders
Published on 04/02/2026 at 15:00, 3 hours 33 minutes ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 3 hours 53 minutes ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 4 hours 3 minutes ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/02/2026 at 14:10, 4 hours 23 minutes ago Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care
Published on 04/02/2026 at 14:00, 4 hours 33 minutes ago Electrovaya Collaborates on U.S. Department of Energy-Funded Project to Advance Energy Storage for Critical Infrastructure
Published on 04/02/2026 at 17:45, 47 minutes ago Minority Shareholders of DKSH Holdings (Malaysia) Berhad Reject Take-Over Offer by DKSH Holding Ltd. at Extraordinary General Meeting
Published on 04/02/2026 at 17:28, 1 hour 5 minutes ago hep global GmbH recommends approving the jointly agreed, amended resolution proposal of SdK in the voting without a meeting from 12 to 14 April 2026
Published on 04/02/2026 at 18:30, 3 minutes ago Thales met à disposition son Document d’Enregistrement Universel 2025
Published on 04/02/2026 at 18:30, 3 minutes ago Thales makes available its Universal Registration Document 2025
Published on 04/02/2026 at 18:22, 10 minutes ago TF1 - Déclaration mensuelle des actions et droits de vote - Mars 2026
Published on 04/02/2026 at 18:22, 10 minutes ago TF1 - Monthly disclosure of the total number of shares and voting rights - March 2026
Published on 04/02/2026 at 18:00, 33 minutes ago Information concerning the total number of voting rights and shares in the share capital as of March 27, 2026